Novo, Giuseppina <br/><br/>
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience.  [electronic resource] 

 -  Oncology  2020 
 - 445-451 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000505486  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Coronary Artery Disease--chemically induced<br/>Dasatinib--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Fusion Proteins, bcr-abl--antagonists & inhibitors<br/>Gastrointestinal Neoplasms--drug therapy<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Humans<br/>Imatinib Mesylate--adverse effects<br/>Imidazoles--adverse effects<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Protein Kinase Inhibitors--adverse effects<br/>Pulse Wave Analysis<br/>Pyridazines--adverse effects<br/>Pyrimidines--adverse effects<br/>Retrospective Studies<br/>Treatment Outcome